Silvan Turkcan Analyst PerformanceAnalyst at Citizens JmpSilvan Turkcan is a stock analyst at Citizens Jmp focused in the healthcare sector, covering 12 publicly traded companies. Over the past year, Silvan Turkcan has issued 25 stock ratings, including buy and hold recommendations. While full access to Silvan Turkcan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Silvan Turkcan's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings25 Last 0 YearsBuy Recommendations96.00% 24 Buy RatingsCompanies Covered12 Unique Companies Ratings Distribution25RatingsDistribution of strong buy, buy, hold, and sell ratings by Silvan Turkcan.RatingPercentageCount Strong Buy0.0%0 ratings Buy96.0%24 ratings Hold4.0%1 ratings Sell0.0%0 ratingsOut of 25 total stock ratings issued by Silvan Turkcan at Citizens Jmp, the majority (96.0%) have been Buy recommendations, followed by 4.0% Hold.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ12 companiesSilvan Turkcan, an analyst at Citizens Jmp, currently covers 12 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare11 companies91.7%Communication Services1 company8.3%Silvan Turkcan of Citizens Jmp specializes in stock coverage within the Healthcare sector, with additional focus on Communication Services companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY11 companies91.7%DIVERSIFIED TELECOMMUNICATION SERVICES1 company8.3% Silvan Turkcan's Ratings History at Citizens Jmp Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsIDYAIDEAYA Biosciences9/1/2026Reiterated Rating$39.49$42.00Market Outperform$0.0000.00% ROICRSPCRISPR Therapeutics8/31/2026Reiterated Rating$57.72$80.00Market Outperform$0.0000.00% ROINTLAIntellia Therapeutics8/25/2026Reiterated Rating$12.56$30.00Market Outperform$0.0000.00% ROICRSPCRISPR Therapeutics8/25/2026Reiterated Rating$57.08$80.00Market Outperform$0.0000.00% ROIHURATuHURA Biosciences8/18/2026Reiterated Rating$2.28$9.00Market Outperform$0.0000.00% ROICELCCelcuity8/17/2026Reiterated Rating$92.00$177.00Market Outperform$0.0000.00% ROIRLAYRelay Therapeutics8/10/2026Boost Price Target$19.77$26.00Market Outperform$0.0000.00% ROIFTHSensei Biotherapeutics7/20/2026Initiated Coverage$25.87$51.00Outperform$0.0000.00% ROIBANDBandwidth7/20/2026Boost Price Target$73.74$86.00Market Outperform$0.0000.00% ROICELCCelcuity7/15/2026Boost Price Target$92.61$177.00Market Outperform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CRSPCRISPR Therapeutics7/6/2026Reiterated Rating$60.08$80.00Market Outperform$0.0000.00% ROITSHATaysha Gene Therapies7/2/2026Reiterated Rating$6.65$11.00Market Outperform$0.0000.00% ROIEXELExelixis6/24/2026Boost Price Target$51.34$55.00Market Outperform$0.0000.00% ROINTLAIntellia Therapeutics6/15/2026Reiterated Rating$13.39$30.00Market Outperform$0.0000.00% ROIRLAYRelay Therapeutics5/20/2026Boost Price Target$12.07$21.00Market Outperform$0.0000.00% ROIENGNenGene5/8/2026Downgrade$1.72Market Perform$0.0000.00% ROICELCCelcuity5/4/2026Boost Price Target$146.64$160.00Market Outperform$0.0000.00% ROIRLAYRelay Therapeutics4/28/2026Boost Price Target$13.52$19.00Market Outperform$0.0000.00% ROINTLAIntellia Therapeutics4/28/2026Boost Price Target$13.64$30.00Market Outperform$0.0000.00% ROICELCCelcuity4/27/2026Initiated Coverage$121.03$150.00Market Outperform$0.0000.00% ROIHURATuHURA Biosciences4/27/2026Initiated Coverage$2.35$9.00Market Outperform$0.0000.00% ROICLLSCellectis4/14/2026Reiterated Rating$4.28$8.00Market Outperform$0.0000.00% ROIRLAYRelay Therapeutics3/17/2026Boost Price Target$10.01$17.00Market Outperform$0.0000.00% ROINTLAIntellia Therapeutics3/3/2026Boost Price Target$15.44$28.00Market Outperform$0.0000.00% ROICRSPCRISPR Therapeutics1/30/2026Lower Price Target$53.35$80.00Market Outperform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
